The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Catheter Fibrinolysis Cuts Early Risk in Pulmonary Embolism

Ultrasound-facilitated catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone reduces clinical deterioration in patients with acute intermediate-risk pulmonary embolism.

Tape Strips Detect Immune Markers in Orphan Ichthyoses

Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across four orphan ichthyoses, pilot study shows.

Dendritic Cell Strategies May Reduce Cancer Recurrence Risk

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

Sunflower Seed Sensitization Outpaces True Allergy in Kids

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding Steroid Shows No Heart Benefit in Kawasaki Disease

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Torque Teno Virus Predicts Malignancy Post-Kidney Transplant

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

Ultrasound-facilitated catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone reduces clinical deterioration in patients with acute intermediate-risk pulmonary embolism.

Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across four orphan ichthyoses, pilot study shows.

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

News All Time

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

US FDA Expands Approval for Travere's Drug for Rare Kidney Disease

The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' ⁠drug to treat a rare kidney disorder, the company said on Monday.

EPP and XLP: Dersimelagon Delays Photodermatoses Prodrome

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

Preparing for the Next Pandemic: What the EU Wants

The EU aims to offer pharmaceutical companies ‘workable terms’ in policies designed to improve future pandemic response.

Gastritis Study Reveals Antibody-Anemia Connection

Anemia is common in patients with autoimmune gastritis and is associated with positivity for anti-intrinsic factor antibodies.

Pemphigus: Rituximab Shows Lower Cancer Risk Than Other Txs

Rituximab is linked to a lower 5-year risk for new cancer than mycophenolate mofetil or azathioprine in patients with pemphigus, study shows.

Nemolizumab Findings Positive for Younger Kids With AD

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Systemic Onychomycosis Rxs: Hepatoxicity Risks Compared

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

‘Unchartered Territory’: CAR T Results in Ped Rheumatology

Among the challenges of conducting larger clinical trials is identifying appropriate patient populations.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Consider Kids’ Sports Gear as a Source of Contact Dermatitis

Modifications and alternative products can help manage sports-related allergens in children with allergic contact dermatitis.

Recommended News For You

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

Exercise may help breast cancer survivors manage weight

Novel Psychedelic Promising on Resistant Depression

Outcomes in Resected Melanoma Influenced by Timing of Recurrence

FDA Approves New Drug Combo for RR Multiple Myeloma

Recommended Articles For You

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies 

Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response 

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role 

What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

2.

Minimally invasive prostate cancer treatment shows success in first patient

3.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

4.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

5.

Cancerous breast tissue glows in new AI-enhanced MRI images

1.

Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction

2.

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment

3.

Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment

4.

Understanding Dasatinib: A Promising Drug for Cancer Treatment 

5.

Hemophilia: Pathophysiology, Genetics, and Treatment Advances

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part XVI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot